Climb Bio Inc share price logo

Climb Bio Inc

NASDAQ: CLYM

Small Cap

$12.20

+0.75

(+6.55%)

as on

Climb Bio Inc Stock Performance

as on May 7, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $11.31
    $12.35
    downward going graph

    7.30%

    Downside

    1.23%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.13
    $11.49
    downward going graph

    90.74%

    Downside

    -5.82%

    Upside

    downward going graph

Climb Bio Inc share price movements today

Previous Close
$11.45
Open
$11.48
Volume
1.5M
Day's Low - High
$11.31 - $12.35
52 Week Low - High
$1.13 - $11.49

Climb Bio Inc Historical Returns

1 Month Return
+ 69.88 %
3 Month Return
+ 110.48 %
1 Year Return
+ 854.17 %
3 Year Return
0 %
5 Year Return
0 %

Climb Bio Inc Stock Fundamentals & Key Indicators

Check Climb Bio Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$462.9M

EPS (TTM)

-1.1488

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-32.15%

Climb Bio Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Climb Bio Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Climb Bio Inc image
Climb Bio Inc
NA$462.9MNANA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$40.2B127.94%75.8512.55%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$107.9B99.08%25.1832.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$33.1BNA120.445.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$73.6B40.83%17.1329.65%

Stock Returns calculator for Climb Bio Inc Stock including INR - Dollar returns

The Climb Bio Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Climb Bio Inc investment value today

Current value as on today

₹11,40,939

Returns

₹10,40,939

(+1.04K%)

Returns from Climb Bio Inc Stock

₹9,16,667 (+916.67%)

Dollar Impact

₹1,24,272 (+124.27%)

Indian Investors' Interest in Climb Bio Inc Stock

Search interest for Climb Bio Inc Stock has increased by 300% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:300% versus previous 30 day period

Climb Bio Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
0
0
0
Operating Income
-5
-5
-3
-56
-11
-10
-23
-10
-14
-19
EBITDA
-5
-5
-3
-56
-11
-10
-23
-8
-12
-19
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
0
0
Income Before Tax
-3
-3
-1
-54
-8
-8
-20
-8
-12
-17
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-3
-3
-1
-54
-8
-8
-20
-8
-12
-17
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Climb Bio Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
0
Operating Income
-20
-35
-45
-40
-82
-67
EBITDA
-11
-35
-45
-40
-30
-67
Interest Expense
-
-
-
-
-
-
Depreciation
-
-
-
-
-
0
Income Before Tax
-20
-47
-45
-35
-73
-59
Income Tax Expense
-
-
-
-
-
-
Net Income
-20
-47
-45
-35
-73
-59
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Climb Bio Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-3
-1
-54
-8
-8
-20
-8
-12
-17
Operating Cash Flow
0
-1
0
-7
-5
-15
-11
-12
-15
Investing Cash Flow
36
13
-9
-71
-53
-42
4
15
25
Financing Cash Flow
0
0
128
2
0
-
-
-
0
Change in Cash
35
11
118
-76
-58
-58
-6
3
9

Climb Bio Inc Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-20
-47
-45
-35
-73
-59
Operating Cash Flow
-14
-36
-37
-20
-15
-54
Investing Cash Flow
8
-114
34
68
-121
2
Financing Cash Flow
4
177
-
0
130
0
Change in Cash
0
26
-3
49
-5
-51

Insights on Climb Bio Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, CLYM has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, CLYM stock has moved up by 525.7%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, CLYM has outperformed top 5 stocks with highest market-cap in its industry

About Climb Bio Inc

Climb Bio, Inc., a clinical-stage biotechnology company, focuses on developing therapies to address unmet needs for patients living with immune-mediated diseases. The company's lead product candidate is the budoprutug, an anti-CD19 monoclonal antibody for the treatment of B-cell mediated diseases. It is also developing budoprutug which is in phase 2 clinical trials for the treatment of primary membranous nephropathy and immune thrombocytopenia; and Phase 1b clinical trial indicated for the systemic lupus erythematosus. In addition, the company is developing CLYM116, a preclinical stage anti A Proliferation-inducing Ligand (APRIL) monoclonal antibody for the treatment of immunoglobin A nephropathy (IgAN) and other B-cell mediated diseases. The company was formerly known as Eliem Therapeutics, Inc. and changed its name to Climb Bio, Inc. in October 2024. Climb Bio, Inc. was incorporated in 2018 and is headquartered in Wellesley Hills, Massachusetts.
OrganisationClimb Bio Inc
Headquarters20 William Street, Wellesley Hills, MA, United States, 02481
IndustryBiotechnology
CEODr. Susan Altschuller M.B.A., Ph.D.
E-voting on sharesClick here to vote

Key Management of Climb Bio Inc

Name

Title

Dr. Susan Altschuller M.B.A., Ph.D.

CFO & Principal Accounting Officer

Dr. Perrin Wilson B.S., Ph.D.

Chief Business Officer

FAQs

What is Climb Bio Inc share price today?

Climb Bio Inc share price today is $12.2 as on at the close of the market. Climb Bio Inc share today touched a day high of $12.35 and a low of $11.31.

What is the 52 week high and 52 week low for Climb Bio Inc share?

Climb Bio Inc share touched a 52 week high of $11.49 on and a 52 week low of $1.13 on . Climb Bio Inc stock price today i.e. is closed at $12.2,which is -6.18% down from its 52 week high and 979.65% up from its 52 week low.

What is Climb Bio Inc's market capitalisation today?

Climb Bio Inc market capitalisation is $0.00T as on .

How to invest in Climb Bio Inc Stock (CLYM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Climb Bio Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Climb Bio Inc Shares that will get you 0.1230 shares as per Climb Bio Inc share price of $12.2 per share as on May 7, 2026 at 1:29 am IST.

What is the minimum amount required to buy Climb Bio Inc Stock (CLYM) from India?

Indian investors can start investing in Climb Bio Inc (CLYM) shares with as little as ₹94.61 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.10 in Climb Bio Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Climb Bio Inc share’s latest price of $12.2 as on May 7, 2026 at 1:29 am IST, you will get 0.8197 shares of Climb Bio Inc. Learn more about fractional shares .